Crystal structure of the mouse hepatitis virus ns2 phosphodiesterase domain that antagonizes RNase L activation

Journal of General Virology

Volumn 97, Issue 4, 2016, Pages 880-886

  Sui, Baokun ^a   Huang, Junhua ^a   Jha, Babal K ^b   Yin, Ping ^a   Zhou, Ming ^a   Fu, Zhen F ^c   Silverman, Robert H ^b   Weiss, Susan R ^d   Peng, Guiqing ^a   Zhao, Ling ^a  

^a HUAZHONG AGRICULTURAL UNIVERSITY   (China)

^b LERNER RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF GEORGIA   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2',5' PHOSPHODIESTERASE; ARGININE; INTERFERON; NONSTRUCTURAL PROTEIN 2; PROTEIN VP3; RIBONUCLEASE L; UNCLASSIFIED DRUG; 2-5A-DEPENDENT RIBONUCLEASE; AKAP7 PROTEIN, MOUSE; CYCLIC AMP DEPENDENT PROTEIN KINASE ANCHORING PROTEIN; PHOSPHODIESTERASE; RECOMBINANT PROTEIN; RIBONUCLEASE; VIRAL PROTEIN;

ARTICLE; BETA SHEET; CARBOXY TERMINAL SEQUENCE; ENZYME ACTIVATION; ENZYME ACTIVITY; MURINE HEPATITIS VIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN STRUCTURE; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY; WESTERN BLOTTING; ANIMAL; CHEMISTRY; CONSERVED SEQUENCE; ENZYME ACTIVE SITE; ENZYMOLOGY; ESCHERICHIA COLI; GENE EXPRESSION; GENETICS; METABOLISM; MOLECULAR CLONING; MOLECULAR GENETICS; MOLECULAR MODEL; MOUSE; PROTEIN DOMAIN; PROTEIN MOTIF; PROTEIN SECONDARY STRUCTURE; ROTAVIRUS; STRUCTURAL HOMOLOGY; X RAY CRYSTALLOGRAPHY;

A KINASE ANCHOR PROTEINS; AMINO ACID MOTIFS; ANIMALS; CATALYTIC DOMAIN; CLONING, MOLECULAR; CONSERVED SEQUENCE; CRYSTALLOGRAPHY, X-RAY; ENDORIBONUCLEASES; ESCHERICHIA COLI; GENE EXPRESSION; MICE; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MURINE HEPATITIS VIRUS; PHOSPHORIC DIESTER HYDROLASES; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN STRUCTURE, SECONDARY; RECOMBINANT PROTEINS; ROTAVIRUS; STRUCTURAL HOMOLOGY, PROTEIN; VIRAL NONSTRUCTURAL PROTEINS;

EID: 84963726977     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/jgv.0.000395     Document Type: Article

References (28)

1. Adams, P. D., Grosse-Kunstleve, R. W., Hung, L.-W., Ioerger, T. R., McCoy, A. J., Moriarty, N. W., Read, R. J., Sacchettini, J. C., Sauter, N. K. & Terwilliger, T. C. (2002). PHENIX: building new software for automated crystallographic structure determination. Acta Crystallogr D Biol Crystallogr 58, 1948–1954.
2. Brandmann, T. & Jinek, M. (2015). Crystal structure of the C-terminal 2ʹ, 5ʹ-phosphodiesterase domain of group A rotavirus protein VP3. Proteins 83, 997–1002.
3. Cole, J. L., Carroll, S. S., Blue, E. S., Viscount, T. & Kuo, L. C. (1997). Activation of RNase L by 2ʹ, 5ʹ-oligoadenylates. Biophysical characterization. J Biol Chem 272, 19187–19192.
4. Der, S. D., Zhou, A., Williams, B. R. & Silverman, R. H. (1998). Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays. Proc Natl Acad Sci U S A 95, 15623–15628.
5. Desselberger, U. (2014). Rotaviruses. Virus Res 190, 75–96.
6. Dong, B. & Silverman, R. H. (1995). 2-5A-dependent RNase molecules dimerize during activation by 2-5A. J Biol Chem 270, 4133–4137.
7. Emsley, P. & Cowtan, K. (2004). Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr 60, 2126–2132.
8. Gold, M. G., Smith, F. D., Scott, J. D. & Barford, D. (2008). AKAP18 contains a phosphoesterase domain that binds AMP. J Mol Biol 375, 1329–1343.
9. Gusho, E., Zhang, R., Jha, B. K., Thornbrough, J. M., Dong, B., Gaughan, C., Elliott, R., Weiss, S. R. & Silverman, R. H. (2014). MurineAKAP7 has a 2ʹ, 5ʹ-phosphodiesterase domain that can complement an inactive murine coronavirus ns2 gene. MBio 5, e01312–e01314.
10. Han, Y., Donovan, J., Rath, S., Whitney, G., Chitrakar, A. & Korennykh, A. (2014). Structure of human RNase L reveals the basis for regulated RNA decay in the IFN response. Science 343, 1244–1248.
11. Heras, B. & Martin, J. L. (2005). Post-crystallization treatments for improving diffraction quality of protein crystals. Acta Crystallogr D Biol Crystallogr 61, 1173–1180.
12. Hovanessian, A. G. & Justesen, J. (2007). The human 2ʹ-5’oligoadenylate synthetase family: unique interferon-inducible enzymes catalyzing 2ʹ-5ʹ instead of 3ʹ-5ʹ phosphodiester bond formation. Biochimie 89, 779–788.
13. Huang, H., Zeqiraj, E., Dong, B., Jha, B. K., Duffy, N. M., Orlicky, S., Thevakumaran, N., Talukdar, M., Pillon, M. C. & other authors (2014). Dimeric structure of pseudokinase RNase L bound to 2-5A reveals a basis for interferon-induced antiviral activity. Mol Cell 53, 221–234.
14. Kerr, I. M. & Brown, R. E. (1978). pppA2’p5’A2’p5’A: an inhibitor of protein synthesis synthesized with an enzyme fraction from interferon-treated cells. Proc Natl Acad Sci U S A 75, 256–260.
15. Kristiansen, H., Gad, H. H., Eskildsen-Larsen, S., Despres, P. & Hartmann, R. (2011). The oligoadenylate synthetase family: an ancient protein family with multiple antiviral activities. J Interferon Cytokine Res 31, 41–47.
16. Luytjes, W., Bredenbeek, P. J., Noten, A. F., Horzinek, M. C. & Spaan, W. J. (1988). Sequence of mouse hepatitis virus A59 mRNA 2: indications for RNA recombination between coronaviruses and influenza C virus. Virology 166, 415–422.
17. Ogden, K. M., Hu, L., Jha, B. K., Sankaran, B., Weiss, S. R., Silverman, R. H., Patton, J. T. & Prasad, B. V. (2015). Structural basis for 29-59-oligoadenylate binding and enzyme activity of a viral RNase L antagonist. J Virol 89, 6633–6645.
18. Otwinowski, Z. & Minor, W. (1997). Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol 276, 307–326.
19. Schindler, C. & Darnell, J. E. Jr. (1995). Transcriptional responses to polypeptide ligands: the JAK-STAT pathway. Annu Rev Biochem 64, 621–652.
20. Silverman, R. H. (2007). Viral encounters with 29, 59-oligoadenylate synthetase and RNase L during the interferon antiviral response. J Virol 81, 12720–12729.
21. Silverman, R. H. & Weiss, S. R. (2014). Viral phosphodiesterases that antagonize double-stranded RNA signaling to RNase L by degrading 2-5A. J Interferon Cytokine Res 34, 455–463.
22. Stark, G. R., Kerr, I. M., Williams, B. R., Silverman, R. H. & Schreiber, R. D. (1998). How cells respond to interferons. Annu Rev Biochem 67, 227–264.
23. Thakur, C. S., Xu, Z., Wang, Z., Novince, Z. & Silverman, R. H. (2005). A convenient and sensitive fluorescence resonance energy transfer assay for RNase L and 2ʹ, 5ʹ oligoadenylates. Methods Mol Med 116, 103–113.
24. Wang, Q. & Carmichael, G. G. (2004). Effects of length and location on the cellular response to double-stranded RNA. Microbiol Mol Biol Rev 68, 432–452.
25. Zaki, A. M., van Boheemen, S., Bestebroer, T. M., Osterhaus, A. D. & Fouchier, R. A. (2012). Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med 367, 1814–1820.
26. Zhang, R., Jha, B. K., Ogden, K. M., Dong, B., Zhao, L., Elliott, R., Patton, J. T., Silverman, R. H. & Weiss, S. R. (2013). Homologous 2ʹ, 5ʹ-phosphodiesterases from disparate RNA viruses antagonize antiviral innate immunity. Proc Natl Acad Sci U S A 110, 13114–13119.
27. Zhao, L., Rose, K. M., Elliott, R., Van Rooijen, N. & Weiss, S. R. (2011). Cell-type-specific type I interferon antagonism influences organ tropism of murine coronavirus. J Virol 85, 10058–10068.
28. Zhao, L., Jha, B. K., Wu, A., Elliott, R., Ziebuhr, J., Gorbalenya, A. E., Silverman, R. H. & Weiss, S. R. (2012). Antagonism of the interferon-induced OAS-RNase L pathway by murine coronavirus ns2 protein is required for virus replication and liver pathology. Cell Host Microbe 11, 607–616.